Report Overview
The neurorehabilitation devices market, with a 12.07% CAGR, is expected to grow to USD 3.679 billion in 2031 from USD 1.857 billion in 2025.
Highlights:
- 1Growing prevalence of neurological disorders driving market demandThe increasing incidence of stroke, traumatic brain injury, spinal cord injury, Parkinson’s disease, and multiple sclerosis is significantly boosting demand for neurorehabilitation therapies and technologies aimed at improving functional recovery and patient quality of life.
- 2Technological advancements transforming rehabilitation practicesInnovations such as robotic exoskeletons, brain-computer interfaces, virtual reality systems, wearable devices, and neurostimulation technologies are revolutionizing neurorehabilitation by enabling personalized, precise, and more effective treatment approaches.
- 3Rising emphasis on functional recovery and patient independenceHealthcare providers are increasingly focusing on restoring mobility, motor skills, and independence in patients with neurological impairments, which is accelerating the adoption of comprehensive neurorehabilitation programs across hospitals, clinics, rehabilitation centers, and home care settings.
- 4North America leading the global market with strong infrastructure and investmentsNorth America is expected to hold a substantial market share due to advanced healthcare infrastructure, supportive reimbursement policies, high neurological disease prevalence, and strong research and development investments by major companies such as Medtronic plc and Abbott Laboratories.
Neurorehabilitation alludes to different treatments, mediations, and hardware that are planned to advance utilitarian recuperation, reestablish versatility, and work on personal satisfaction in patients experiencing neurological illnesses or mishaps. Stroke, spinal rope injury, Parkinson's infection, different sclerosis, and different issues might be among them.
The Neurorehabilitation market size is growing quickly, attributable to an expansion in the recurrence of neurological illnesses, mechanical enhancements, and steady government endeavors. As the discipline is created, there is huge potential for extra advances in neurorehabilitation methodology and hardware, eventually prompting improved results and a better life for those with neurological impedances.
Neurorehabilitation Market Growth Drivers:
Increasing Prevalence of Neurological Disorders:
As the rate of neurological ailments like stroke, horrendous mind injury, and numerous cases of sclerosis rises, so does the interest in neurorehabilitation medicines. Market expansion is driven by the growing demand for effective rehabilitation solutions from this expanding patient population.
Technological Advancements in Rehabilitation Devices:
Advanced rehabilitation technologies like robotic exoskeletons, brain-computer interfaces, and virtual reality systems have revolutionized neurorehabilitation. These state-of-the-art contraptions convey precise and customized treatment activities, tempting medical services experts and impelling business sector development.
Growing Focus on Functional Recovery and Quality of Life:
There is a developing accentuation on upgrading practical recuperation and working on personal satisfaction for those with neurological infections. By providing comprehensive rehabilitation programs, neurorehabilitation plays a crucial role in achieving these goals, leading to increased demand and market expansion.
Neurorehabilitation Market Key Players:
Medtronic PLC: Medtronic is a worldwide clinical innovation supplier that gives an exhaustive scope of neurorehabilitation gear and treatments. Neurostimulation frameworks, implantable gadgets, and other new answers for the treatment of neurological ailments are important for their portfolio.
DIH Medical Group: DIH’s subsidiary Hocoma AG manufactures sensor-based neurorehabilitation systems. Automated treatment frameworks, augmented reality stages, and sensor-helped restoration gear for upper and lower appendage recovery are among their contributions.
Saebo Inc.: Saebo is a company that specializes in upper limb rehabilitation equipment and solutions. They provide several goods, including functional orthoses and robotic treatment systems, to help people with neurological problems improve their hand and arm function.
Neurorehabilitation Market Geographical Outlook:
North America is anticipated to hold a considerable neurorehabilitation market share.
North America is projected to account for a significant market share which is attributable to various factors. Firstly, the region contains sophisticated healthcare infrastructure, such as specialized rehabilitation centers and research organizations, which encourage the use of neurorehabilitation technology. Also, neurological illnesses are common in North America, increasing the requirement for appropriate rehabilitation methods. Furthermore, favorable reimbursement regulations and government activities promoting neurorehabilitation contribute to the region's neurorehabilitation market share. Furthermore, the presence of significant companies in North America, as well as continuing expenditures in research and development operations, reinforce its market position in the Neurorehabilitation market.
Neurorehabilitation Market Key Developments:
In February 2023, Lupin Limited launched the first-of-its-kind computer and robotic-assisted Neurorehabilitation Center “Atharv Ability” in Mumbai. The center would provide rehabilitation programs for patients suffering from spinal cord & brain injury and other neurological conditions such as Parkinson's, multiple sclerosis, and cerebral palsy.
Neurorehabilitation Market Scope:
| Report Metric | Details |
|---|---|
| Total Market Size in 2025 | USD 1.857 billion |
| Total Market Size in 2031 | USD 3.679 billion |
| Forecast Unit | USD Billion |
| Growth Rate | 12.07% |
| Study Period | 2020 to 2031 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2031 |
| Segmentation | Product, Application, End-user, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies |
|
Market Segmentation
By Product
By Application
By End-user
By Geography
Table of Contents
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. NEUROREHABILITATION MARKET BY PRODUCT
5.1. Introduction
5.2. Neuro-Robotic System
5.3. Wearable Devices
5.4. Brain Computer Interface
5.5. Non-Invasive Stimulators
5.6. Neuronal Prosthetics
5.7. Others
6. NEUROREHABILITATION MARKET BY APPLICATION
6.1. Introduction
6.2. Stroke
6.3. Traumatic Brain Injury (TBI)
6.4. Spinal Cord Injury (SCI)
6.5. Parkinson's Disease
6.6. Cerebral Palsy
6.7. Others
7. NEUROREHABILITATION MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Rehabilitation Centers
7.5. Home Care Settings
8. NEUROREHABILITATION MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medtronic plc
10.2. Abbott Laboratories
10.3. Bionik Laboratories Corp.
10.4. Ekso Bionics Holdings, Inc.
10.5. DIH Medical Group
10.6. ReWalk Robotics
10.7. BioXtreme Ltd.
10.8. Kinova
10.9. Saebo Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES
Navigate
Trusted by the world's leading organizations











